Target intelligence / Profile preview

Probable transcriptional regulatory protein Rv0078 (EthR2)

Target
EthR2
Molecular classification
Transcription factor, DNA-binding protein
01

Overview

EthR2 (Probable transcriptional regulatory protein Rv0078) is a TetR-family transcriptional repressor in Mycobacterium tuberculosis that regulates the expression of the alternative ethionamide-activating monooxygenase EthA2 (also known as MymA). Ethionamide is a crucial second-line prodrug used to treat multidrug-resistant tuberculosis, but its clinical utility is severely limited by dose-dependent hepatotoxicity and gastrointestinal side effects, as well as the rapid emergence of resistance mutations in its primary activating enzyme, EthA. By binding to and inhibiting EthR2, small-molecule adjuvants (such as alpibectir or SMARt-420) induce a conformational change that prevents EthR2 from binding to its target DNA. This derepresses the alternative activation pathway, allowing EthA2/MymA to bioactivate ethionamide into its active form. Consequently, this booster strategy dramatically increases the potency of ethionamide, allowing for a significant reduction in the therapeutic dose and overcoming established EthA-mediated drug resistance.

Other names
EthR2Rv0078EthR2 transcriptional regulatorEthR2 transcriptional repressorTetR-family transcriptional regulator Rv0078
02

Mechanism of action

Inhibition of the EthR2 transcriptional repressor, which derepresses the expression of the alternative monooxygenase EthA2 (also known as MymA). This increases the bioactivation of the prodrug ethionamide into its active sulfoxide metabolite, thereby potentiating ethionamide efficacy and overcoming resistance caused by mutations in the primary activating enzyme EthA.

03

Biological functions

Regulation of transcriptionDNA binding
04

Disease associations

Infection
05

Safety considerations

HepatotoxicityGastrointestinal intolerabilitySecondary resistance development
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

EthA mutation statusEthA2 expression levelMymA expression levelMycobacterial load

Beyond the preview

Go deeper on Probable transcriptional regulatory protein Rv0078 (EthR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable transcriptional regulatory protein Rv0078 (EthR2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call